D. Dejong et al., HISTOLOGICAL GRADING IN GASTRIC LYMPHOMA - PRETREATMENT CRITERIA AND CLINICAL RELEVANCE, Gastroenterology, 112(5), 1997, pp. 1466-1474
Background & Aims: Stomach-conserving therapy in primary gastric non-H
odgkin's lymphoma (mucosa-associated lymphoid tissue [MALT]-NHL) is in
creasingly gaining importance as an alternative to surgery. As a conse
quence, surgical pathologists have to define histological criteria in
pretreatment endoscopic biopsy specimen samples not only to make the d
iagnosis but also to recognize minor tumor components that may infer a
significantly adverse impact on prognosis. The aim of this study was
to define histological criteria for clinically significant tumor progr
ession in pretreatment endoscopic biopsy specimens. Methods: In a cons
ecutive series of 106 patients with gastric MALT-NHL, the prognostic i
mpact of large cell components was assessed by semiquantitative analys
is of clusters and diffusely intermingled malignant blasts. Results: I
n low-grade MALT-NHL, a category with a diffuse large cell component o
f 1%-10% with or without nonconfluent clusters of blasts could be sepa
rated with a significantly worse prognosis (10-year disease-specific s
urvival, 90% vs. 75%). No clinical parameters of known prognostic sign
ificance could account for this difference. Conclusions: It is possibl
e to define criteria in endoscopic biopsy specimens to recognize clini
cally relevant tumor progression. To serve as a guideline in the choic
e of treatment, these criteria should be validated prospectively in fu
ture clinical trials.